• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

Medtronic Needs to Rebase Before Being Attractive Again

Stand aside and let things "shake out".
By BRUCE KAMICH
Oct 13, 2021 | 11:18 AM EDT
Stocks quotes in this article: MDT

For his second "Executive Decision" segment of Mad Money Tuesday evening, Jim Cramer spoke with Geoff Martha, chairman and CEO of Medtronic (MDT) , ahead of the medical device maker's ESG investor meeting on Wednesday.

Martha said there's a lot going on at Medtronic, including a new brand refresh that will be announced tomorrow. Part of that rebranding will include a new tagline, "engineering the extraordinary," which encapsulates what Medtronic is all about.

Medtronic is at the nexus of healthcare and technology, Martha said, and there is a lot of innovation happening industry wide in the fields of robotics and miniaturization.

Medtronic is also committed to reducing global health disparities, Martha added, and the company is performing more virtual training sessions than ever to bring knowledge of their products worldwide.

When asked about areas like deep brain stimulation, Martha said they do not back away from difficult problems. They continue building technologies to listen for the brain signals that cause tremors in Parkinson's patients, for example, and disrupt them.

Let's check out the charts of MDT. We last visited MDT back on May 24 where we recommended that "The charts of MDT still look good. Longs should raise stop protection to $122. The $150-$160 area is our longer-term price objective after $137." Prices just missed our $137 target but I am hoping that traders took some profits.

Let's check on MDT again.

In this daily bar chart of MDT, below, we can see that prices have weakened the past six weeks and are testing/breaking the 200-day moving average line. The slope of the line is cresting and that can mean that the underside of the average line may act as resistance. We'll see.

The On-Balance-Volume (OBV) line shows a decline the past six weeks telling us that sellers of MDT have been more aggressive. The Moving Average Convergence Divergence (MACD) oscillator is below the zero line in bearish territory.

In this weekly Japanese candlestick chart of MDT, below, we see a weakening picture. Prices are testing/breaking the rising 40-week moving average line. The OBV line is pointed down after making a lower high for a bearish divergence when compared to the price action. The MACD oscillator is pointed down but still above the zero line.

In this daily Point and Figure chart of MDT, below, we can see a possible downside price target of $118.

In this weekly Point and Figure chart of MDT, below, a $110 price target is displayed.

Bottom line strategy: It looks like MDT will be on the defensive for a bit so traders should stand aside and let things "shake out" and then rebase.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Health Care Equipment & Services | Life Sciences | Science | Mad Money | Executive Interview

More from Investing

Mega-Cap Tech Keeps Showing Wall Street Who's Boss

James "Rev Shark" DePorre
Jun 1, 2023 4:28 PM EDT

The action broadened on Thursday, but a small group of big stocks still dominated.

Dollar General Gets Busted Down to Lieutenant

Bruce Kamich
Jun 1, 2023 1:45 PM EDT

The charts advise marching in the other direction for this retailer.

New BlackRock Funds Rely on Brainpower

Mark Abssy
Jun 1, 2023 1:14 PM EDT

Artificial intelligence is all the rage, but the BlackRock Large Cap Value and the BlackRock Flexible Income exchange-traded funds offer a bit of human touch.

I Don't See Any Fireworks Coming From Macy's

Bruce Kamich
Jun 1, 2023 1:06 PM EDT

This iconic retailer appears only headed lower after posting earnings.

Here's How Investors Can Get in on Soaring Uranium Prices

Bruce Kamich
Jun 1, 2023 12:33 PM EDT

The charts of this fund are giving off a positive glow.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 06:54 PM EDT CHRIS VERSACE

    AAP Podcast: A Tongue -- and a Market -- Twister: 'Get a Debt Deal Done'

    Listen in as the Action Alerts PLUS Podcast tackle...
  • 12:07 PM EDT STEPHEN GUILFOYLE

    Selling Some of This Surging AI-Related Stock

    This isn't the only name in the Stocks Under $10 p...
  • 09:48 AM EDT CHRIS VERSACE

    AAP Podcast With Portillo's CEO!

    Listen in as we talk with a rising star in the Chi...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login